Psychotropic drugs in the elderly: Overuse or underuse?;L'utilisation des psychotropes chez le sujet age: Trop ou trop peu?

Presse Medicale

Volumn 28, Issue 32, 1999, Pages 1794-1799

  Fremont P ^a  

^a Centre hospitalier de Lagny Marne la Vallee   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT; RISPERIDONE;

DEPRESSION; DRUG INDICATION; DRUG MISUSE; DRUG UTILIZATION; ELDERLY CARE; HUMAN; PRESCRIPTION; PSYCHOSIS; REVIEW; RISK BENEFIT ANALYSIS; AGED; CLASSIFICATION; MENTAL DISEASE;

AGED; HUMANS; MENTAL DISORDERS; PSYCHOTIC DISORDERS; PSYCHOTROPIC DRUGS;

EID: 0033598514     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Guelfi JD, Falisard B, Lellouch J. Prescrit-on trop d'antidepresseurs en France? Presse Med 1998 ; 27:(40):2126-8.
2. NIH consensus conference Diagnosis and treatment of depression in late life. JAMA 1992 ; 268(8):1018-24.
3. Dupré-Lévêque D. Psychotropes, milieu institutionnel, personnes ågées: quels rapports? Pour une approche anthropologique du médicament psychoactif. Les Cahiers de l'Actif 1998; 270/271:143-54.
4. Navarre C, Colonna L Le point sur l'utilisation des psychotropes chez le sujet ågé. La revue du généraliste et de la gérontologie 1996, 27.
5. Plas J, Regel I. Troubles psychiatriques d'origine iatrogéne chez le sujet ågé. Nervure 1997 ; 10(6)supplément:1-4.
6. Goudemand M, Thomas P. Anxiété, dépression et démence. Rev Prat (Paris) 1994 ; 44(11):1448-52.
7. Salzman C., Scnneider L., Lebowitz B. Antidepressant treatment of very old patients. Am J Geriatr Psychiatry 1993 ; 1(1):21-9.
8. Raskind MA. Management of late-life depression and the noncognitive behavioral disturbances of alzheimer's disease. Psychopharmacology 1993 ; 16(4):815-27.
9. Dwork AJ, Susser ES, Keilp J et al. Senile degeneration and cognitive impairment in chronic schizophrenia. Am J Psychiatry 1998 ; 155(11):1536-43.
10. Waintraub L. La depression du sujet ågé: reconnaisance et traitement. Presse Med 1998 ; 27:(40):2119-44.
11. Maniere D, Pfitzenmeyer P. La dépression du sujet ågé est insuffisament traitée. Rev Prat Médecine Générale 1998 ; 12(410):13-18.
12. Hazif-Thomas C, Thomas Ph. Dépression de la personne ågée: des tableaux souvent atypiques. Rev Gériatr 1998 ; 23(4).
13. Druss BG, Rohrbaugh RM, Rosenheck RA. Depressive symptoms and health costs in older medical patients. Am J Psychiatry 1999 ; 156(3):477-9.
14. Koenig HG, Kuchibhatla M. Use of health services by hospitalized medically ill depressed elderly patients. Am J Psychiatry 1998 ; 155(7):871-7.
15. Skoog I, Aevarsson O, Beskow J et al. Suicidal feelings in a population sample of nondemented 85-year-olds. Am J Psychiatry 1996 ; 153(8):1015-20.
16. Yassa R, Nair NPV, Iskandar H. Late-onset bipolar disorder. Psychiatric clinics of north america 1988 ; 11(1):117-31.
17. Schneider A. L'actualité des troubles bipolaires chapitre6: Troubles bipolaires et sénescence. Act Méd Int Psychiatrie 1997 ; 14 (198):3330-6.
18. Flint AJ. Epidemiology and comorbidity of anxiety disorders in the elderly. Am J Psychiatry 1994 ; 151:640-9.
19. e åge. La revue du généraliste et de la gérontologie 1996 ; 27.
20. Teunisse RJ, Cruysberg JR, Hoefnagels WH, Verbeek AL, Zitman FG. Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome. Lancet 1996 ; 347:794-7.
21. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrcs Society. Diagnosis and treatment of Alzheimer disease and related disorders. JAMA 1997 ; 278(16):1363-71.
22. Petit H, Bakchine S, Dubois B et al. Convergences d'un groupe pluridisciplinaire d'experts français sur les modalités du diagnostic et du traitement médicamenteux de la maladie d'Alzheimer au stade démentiel. Rev Neurol (Paris) 1998 ; 154(5):432-8.
23. Herrman N, Lantctot KL, Naranjo CA. Behavioural disorders in demented elderly patients. Current issues in pharmacotherapy. CNS Drugs 1996 ; 6(4):280-300.
24. Stewart JT. Management of behavior problems in the demented patient. Am Fam Phys 1995 ; 52(8)2311-17.
25. Lykestsos CG, Steele C, Galik E et al. Physical aggression in dementia patients and its relationship to depresion. Am J Psychiatry 1999 ; 156(1):66-71.
26. Burke WJ, Dwan V, Wengel SP, Roccaforte WH, Nadolny GC, Folks DG. The use of selective serotonine reuptake inhibitors for depression and psychosis complicating dementia. Int J Geriat Psychiatry 1997 ; 12:519-25.
27. Pollock B. Clinical relevance of pharmocogenetic variations for geriatric psychopharmacology. Drug information Journal 1996 ; 30:669-74.
28. Skoog I, Nilsson I, Landahl S, Steen B. Mental disorders and the use of psychotropics drugs in a 85-year-old representative urban population. International Psychogeriatics 1993 ; 151:33-48.
29. Dalery J, Sechter D. Modalités pratiques d'un traitement de consolidation. Encephale 1995 ; Sp2:43-5.
30. Reynolds CF. Treatment of depression in late life. Am J Medecine 1994 ; 97(suppl 6A):S39-46. J Geriatr Psychiatry Neurol 1995 ; 8:234-7.
31. Reynolds CF. Treatment of depression in late life. Am J Medecine 1994 ; 97(suppl 6A):S39-46. J Geriatr Psychiatry Neurol 1995 ; 8:234-7.
32. Malauzat D. Thérapeutiques biologiques de la depression du sujet ågé. Neuro-psy 1995 ; numero special:31-6.
33. Jenike MA. Managing depression in the elderly. J Geriatr Psychiatry Neurol 1995 ; 8:197-9.
34. Nyth AL, Gottfries CG. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders a nordic muluicentre study. Br J Psychiatry 1990 ; 157:894-901.
35. Cohn CK, Shrivasta R, Mendels J et al. Double-blind, multicenter comparison of sertraline and amitriptyline in ederly depressed patients. J Clin Psychiatry 1990 ; 51(12, suppl B):28-33.
36. Lantz MS, Marin D. Pharmacologic traitement of agitation in dementia: A comprehensive review. J Geriatr Psychiatry Neurol 1996 ; 9(3):107-19.
37. Goldberg RJ, Goldberg J. Antipsychotics for dementia-related behavioral disturbances in elderly institutionalized patients. Clin Geriatrics 1996 ; 4(2)58-68.
38. Woerner MG, Alvir JM, Kane JM. Neuroleptic treatment of elderly patients. Psychopharmacology Bulletin 1995 ; 31(2)333-7.
39. Woerner MG, Alvir JM, Saltz BL, Lieberman JA, Kane JM. Prospective study of tardive dyskinesia in the elderly: rates and risk factors. Am J Psychiatry 1998; 155(11):1521-8.
40. Jeste DV, Lacro JP, Gilbert PL et al. Treatment of late life schizophrenia with neuroleptics. Schizophr Bull 1993 ; 19(4):817-30.
41. Devanand DP, Marder K, Michaels KS et al. A randomised, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in alzheimer's disease. Am J Psychiatry 1998 ; 155(11):1512-20.
42. Ginestet D. Le renouveau des neuroleptiques: les antipsychotiques? Presse Med 1998 ; 27:(40):2164-9.
43. Lipski PS, Death JW. Risperidone in the treatment of agitated and agressive patients with dementia. Australian Journal on Ageing 1995 ; 13(4):151-4.
44. Satterlee WG, Reams SG, Burns PR, Hamilton S, Tran PV, Tollefson GD. A clinical update on olanzapine treatment in schizophrenia and in elderly Alzheimer's disease patients. Psychopharmacology Bulletin 1995 ; 31(3):534.
45. Sciolla A, Jeste DV. Use of antipsychotics in the elderly. Int J Psych Clin Pract 1998 ; 2(suppl 1):s27-34.
46. Taylor S, Mc Craken C, Wilson K, Copeland J. Extent and appropriateness of benzodiazepine use. Br J Psychiatry 1998 ; 173:433-8.
47. Williams D, Mc Bryth A. Benzodiazepines: time for reassessment Br J Psychiatry 1998 ; 173:361-2.
48. Kando JC, Tohen M, Castillo J, Zarate CA. The use of valproate in elderly population with affective symptoms. J Clin Psychiatry 1996 ; 57:238-40.
49. Puryear L, Kunik ME, Workman R. Tolerability of divalproex sodium in elderly psychiatric patients with mixted diagnoses. J Geriatr Psychiatry Neurol 1995 ; 8:234-7.
50. Kunik ME, Puryear L, Orengo CA, Molinari V, Workman RH. The efficacy and tolerability of divalproex sodium in elderly demented patients witih beavioral disturbances. Int J Geriat Psychiatry 1998 ; 13:29-34.
51. Tariot PN, Erb R, Podgorski CA et al. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry 1998 ; 155(1):54-61.